Articles with public access mandates - Tomasz ŚliwińskiLearn more
Not available anywhere: 1
STI571 reduces NER activity in BCR/ABL-expressing cells
T Sliwinski, A Czechowska, J Szemraj, Z Morawiec, T Skorski, J Blasiak
Mutation Research/Genetic Toxicology and Environmental Mutagenesis 654 (2 …, 2008
Mandates: US National Institutes of Health
Available somewhere: 26
Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile
K Cramer-Morales, M Nieborowska-Skorska, K Scheibner, M Padget, ...
Blood, The Journal of the American Society of Hematology 122 (7), 1293-1304, 2013
Mandates: US National Institutes of Health, Cancer Research UK, Wellcome Trust
Tyrosine kinase inhibitor–induced defects in DNA repair sensitize FLT3 (ITD)-positive leukemia cells to PARP1 inhibitors
S Maifrede, M Nieborowska-Skorska, K Sullivan-Reed, Y Dasgupta, ...
Blood, The Journal of the American Society of Hematology 132 (1), 67-77, 2018
Mandates: US National Institutes of Health, Austrian Science Fund, German Research …
RAD52 as a potential target for synthetic lethality-based anticancer therapies
M Toma, K Sullivan-Reed, T Śliwiński, T Skorski
Cancers 11 (10), 1561, 2019
Mandates: US National Institutes of Health
PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas
M Czyż, M Toma, A Gajos-Michniewicz, K Majchrzak, G Hoser, J Szemraj, ...
Oncotarget 7 (46), 75551, 2016
Mandates: US National Institutes of Health
Single-nucleotide polymorphisms of genes involved in repair of oxidative DNA damage and the risk of recurrent depressive disorder
P Czarny, D Kwiatkowski, M Toma, P Gałecki, A Orzechowska, ...
Medical Science Monitor: International Medical Journal of Experimental and …, 2016
Mandates: National Health and Medical Research Council, Australia
Enhanced Accumulation of Betulinic Acid in Transgenic Hairy Roots of Senna obtusifolia Growing in the Sprinkle Bioreactor and Evaluation of Their Biological …
T Kowalczyk, P Sitarek, M Toma, P Rijo, E Domínguez‐Martín, I Falcó, ...
Chemistry & Biodiversity 18 (8), e2100455, 2021
Mandates: Fundação para a Ciência e a Tecnologia, Portugal
In vitro assessment of antimicrobial, antioxidant, and cytotoxic properties of saccharin–tetrazolyl and–thiadiazolyl derivatives: the simple dependence of the ph value on …
LMT Frija, E Ntungwe, P Sitarek, JM Andrade, M Toma, T Śliwiński, ...
Pharmaceuticals 12 (4), 167, 2019
Mandates: Fundação para a Ciência e a Tecnologia, Portugal
Diterpenoids from Plectranthus spp. as Potential Chemotherapeutic Agents via Apoptosis
T Śliwiński, P Sitarek, E Skała, V MS Isca, E Synowiec, T Kowalczyk, ...
Pharmaceuticals 13 (6), 123, 2020
Mandates: Fundação para a Ciência e a Tecnologia, Portugal
Anticancer Properties of Plectranthus ornatus-Derived Phytochemicals Inducing Apoptosis via Mitochondrial Pathway
P Sitarek, E Synowiec, T Kowalczyk, G Bangay, T Śliwiński, L Picot, ...
International Journal of Molecular Sciences 23 (19), 11653, 2022
Mandates: Fundação para a Ciência e a Tecnologia, Portugal
Non-NAD-like PARP1 inhibitor enhanced synthetic lethal effect of NAD-like PARP inhibitors against BRCA1-deficient leukemia
M Nieborowska-Skorska, S Maifrede, M Ye, M Toma, E Hewlett, J Gordon, ...
Leukemia & lymphoma 60 (4), 1098-1101, 2019
Mandates: US National Institutes of Health, Austrian Science Fund, European Commission
Relationship between oxidative stress and imatinib resistance in model chronic myeloid leukemia cells
S Głowacki, E Synowiec, M Szwed, M Toma, T Skorski, T Śliwiński
Biomolecules 11 (4), 610, 2021
Mandates: US National Institutes of Health, National Science Centre, Poland
DNA polymerase θ protects leukemia cells from metabolically induced DNA damage
U Vekariya, M Toma, M Nieborowska-Skorska, BV Le, MC Caron, ...
Blood, The Journal of the American Society of Hematology 141 (19), 2372-2389, 2023
Mandates: US National Institutes of Health, Austrian Science Fund, Canadian Institutes …
Synthetic lethality targeting Polθ
M Drzewiecka, G Barszczewska-Pietraszek, P Czarny, T Skorski, ...
Genes 13 (6), 1101, 2022
Mandates: US National Institutes of Health, National Science Centre, Poland
Eradication of LIG4-deficient glioblastoma cells by the combination of PARP inhibitor and alkylating agent
M Toma, M Witusik-Perkowska, M Szwed, R Stawski, J Szemraj, ...
Oncotarget 9 (96), 36867, 2018
Mandates: US National Institutes of Health
Chronic mild stress and venlafaxine treatment were associated with altered expression level and methylation status of new candidate inflammatory genes in PBMCs and brain …
K Bialek, P Czarny, P Wigner, E Synowiec, G Barszczewska, M Bijak, ...
Genes 12 (5), 667, 2021
Mandates: National Science Centre, Poland
An Evaluation of the Novel Biological Properties of Diterpenes Isolated from Plectranthus ornatus Codd. In Vitro and In Silico
P Sitarek, T Kowalczyk, E Synowiec, A Merecz-Sadowska, G Bangay, ...
Cells 11 (20), 3243, 2022
Mandates: Fundação para a Ciência e a Tecnologia, Portugal
Novel allosteric PARP1 inhibitors for the treatment of BRCA-deficient leukemia
E Hewlett, M Toma, K Sullivan-Reed, J Gordon, T Sliwinski, A Tulin, ...
Medicinal Chemistry Research 29, 962-978, 2020
Mandates: US National Institutes of Health
Histone Deacetylases (HDAC) Inhibitor—Valproic Acid Sensitizes Human Melanoma Cells to Dacarbazine and PARP Inhibitor
M Drzewiecka, A Gajos-Michniewicz, G Hoser, D Jaśniak, ...
Genes 14 (6), 1295, 2023
Mandates: US National Institutes of Health, National Science Centre, Poland
MicroRNA profile and iron-related gene expression in hepatitis C-related hepatocellular carcinoma: a preliminary study
R Krupa, W Malecki, P Czarny, J Strycharz, M Jablkowski, R Kordek, ...
Archives of Medical Science: AMS 17 (5), 1175, 2021
Mandates: National Science Centre, Poland
Publication and funding information is determined automatically by a computer program